FREESTYLE LIBRE PRO FLASH GLUCOSE MONITORING SYSTEM

Sensor, Glucose, Invasive

FDA Premarket Approval P150021

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

The freestyle libre pro flash glucose monitoring system is a professional continuous glucose monitoring (cgm) device indicated for detecting trends and tracking patterns in persons (age 18 and older) with diabetes. The system is intended for use by health care professionals and requires a prescription. Readings from the freestyle libre pro sensor are only made available to patients through consultation with a health care professional. The system does not require user calibration with blood glucose values. The freestyle libre pro system aids in the detection of glucose level excursions above or below the desired range, facilitating therapy adjustments. Interpretation of the freestyle libre pro flash glucose monitoring system readings should be based on the trends and patterns analyzed through time using the reports available.

DeviceFREESTYLE LIBRE PRO FLASH GLUCOSE MONITORING SYSTEM
Classification NameSensor, Glucose, Invasive
Generic NameSensor, Glucose, Invasive
ApplicantAbbott Diabetes Care Inc.
Date Received2015-06-19
Decision Date2016-09-23
Notice Date2016-09-26
PMAP150021
SupplementS
Product CodeMDS
Docket Number16M-2971
Advisory CommitteeClinical Chemistry
Expedited ReviewNo
Combination Product No
Applicant Address Abbott Diabetes Care Inc. 1360 South Loop Rd. alameda, CA 94502
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P150021Original Filing
S057 2022-04-01 30-day Notice
S056 2022-02-18 30-day Notice
S055 2022-02-01 30-day Notice
S054 2021-09-03 30-day Notice
S053 2021-02-23 Real-time Process
S052 2020-12-11 30-day Notice
S051 2020-11-27 30-day Notice
S050
S049 2020-07-01 30-day Notice
S048 2020-03-20 30-day Notice
S047 2019-11-20 30-day Notice
S046
S045 2019-08-15 30-day Notice
S044 2019-07-18 30-day Notice
S043 2019-07-12 30-day Notice
S042 2019-05-30 30-day Notice
S041 2019-04-10 30-day Notice
S040 2019-02-04 30-day Notice
S039
S038 2018-12-26 Real-time Process
S037 2018-12-03 Real-time Process
S036 2018-10-31 Normal 180 Day Track
S035 2018-09-27 Normal 180 Day Track
S034 2018-08-29 30-day Notice
S033 2018-08-20 30-day Notice
S032 2018-07-23 30-day Notice
S031 2018-06-18 Real-time Process
S030 2018-06-08 30-day Notice
S029 2018-05-29 30-day Notice
S028 2018-05-01 30-day Notice
S027 2018-05-01 Real-time Process
S026 2018-03-29 30-day Notice
S025 2018-03-19 30-day Notice
S024 2018-03-12 Normal 180 Day Track
S023 2018-03-05 30-day Notice
S022 2018-03-01 30-day Notice
S021 2018-03-01 30-day Notice
S020
S019 2018-01-23 30-day Notice
S018 2018-01-16 30-day Notice
S017 2017-12-01 30-day Notice
S016 2017-12-01 Real-time Process
S015 2017-11-27 30-day Notice
S014 2017-11-27 30-day Notice
S013 2017-11-20 30-day Notice
S012 2017-09-25 Normal 180 Day Track No User Fee
S011 2017-08-02 Real-time Process
S010 2017-06-12 30-day Notice
S009 2017-05-22 135 Review Track For 30-day Notice
S008 2017-05-19 135 Review Track For 30-day Notice
S007 2017-05-02 Real-time Process
S006 2017-04-03 Normal 180 Day Track
S005 2017-03-30 30-day Notice
S004 2016-12-16 135 Review Track For 30-day Notice
S003 2016-12-14 30-day Notice
S002
S001 2016-11-01 Normal 180 Day Track

NIH GUDID Devices

Device IDPMASupp
30357599716876 P150021 000
30357599715626 P150021 000
30357599715619 P150021 000
57599-0715-55 P150021 000
30357599000418 P150021 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.